In this episode, Dr Rizzo interviews Paul M. Hassoun, MD, Johns Hopkins School of Medicine (Baltimore MD), about his research on Pulmonary Arterial Hypertension (PAH), including its pathogenesis, the evaluation required to establish the diagnosis, available therapies, and what is in store for the future direction in treating patients with the PAH.

In this episode, Lisa Jones interviews Annamarie Rodriguez, RDN, LD, FAND, and Abbie Gellman, MS, RD, CDN, on the impact of plant-based nutrition on health, misconceptions about plant-based eating, and what is on the horizon for plant-based eating dietary interventions.

In part 2 of this 2-part episode, Irum Noor, DO, speaks about the differences in treating allergic asthma in children compared with adults, including when a pediatrician should refer a child to a specialist.

In part 1 of this 2-part episode, Irum Noor, DO, speaks about allergic asthma in children, including the risk factors and symptoms that parents/guardians should be aware of and monitor for.

​​​​​In this episode, C. Buddy Creech, MD, MPH, speaks about his team’s research titled “Safety of Live Attenuated Influenza Vaccine in Children With Asthma,” including supply chain issues with influenza vaccine, the difference between influenza vaccines, and the importance in vaccinating children with asthma against influenza.

​​​​​In this episode, Andrew Halayko, PhD, ATSF, summarizes hot topics to be discussed at the American Thoracic Society (ATS) 2022 annual conference, including how COVID-19 has influenced the program agenda and highly anticipated keynote, clinical, and research sessions.

In this episode, Dr Rizzo interviews Geoffrey Chupp, MD, on his team’s research titled "Bronchial Thermoplasty in Patients with Severe Asthma at 5 years: Post-FDA Approval Clinical Trial Evaluating Bronchial Thermoplasty in Severe Persistent Asthma Study." Dr Chupp speaks about the efficacy, safety results, challenges, and controversies of the therapy.

​​​​​​In part 2 of this 2-part episode, James Matera, DO, FACOI, speaks about the infrastructure required for urgent-start peritoneal dialysis (PD) and the urgent-start PD clinical pathway from patient presentation to discharge home.

​​​​​​In part 1 of this 2-part episode, James Matera, DO, FACOI, speaks about the role, benefits, and challenges of urgent-start peritoneal dialysis in adults and children with chronic kidney disease requiring long-term kidney replacement therapy.

In part 2 of this 2-part episode, Dan Martin, MD, speaks about his team's research titled "The Epidemiology of Endometriosis is Poorly Known as the Pathophysiology and Diagnosis are Unclear," including the gaps in endometriosis research, why those gaps are so problematic, and the key takeaways from their research.